Key facts
- This page summarizes Bruce Stroever's Form 4 filing for Bone Biologics Corp (BBLG).
- 1 reported transaction and 5 derivative rows are listed below.
- Accepted by SEC: 19 Sep 2024, 21:33.
Bruce Stroever - 17 Sep 2024 Form 4 Insider Report for Bone Biologics Corp (BBLG)
- Reporting relationship
- Director
- Issuer ticker
- BBLG
- Reported as of
- 17 Sep 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Sep 2024, 21:33:09 UTC
- Prior SEC filing
- 20 Sep 2023
- Next SEC filing
- 06 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Bruce Stroever
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bruce Stroever filed Form 4 for Bone Biologics Corp (BBLG) on 19 Sep 2024.
Change
- Previous filing in this sequence was filed on 20 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BBLG
transaction
Derivative
Non-Employee Stock Option
Award
- Transaction value
- $0
- Shares
- +30,713
- Change %
- Price
- $0.000000
- Shares after
- 30,713
- Date
- 17 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,713
- Exercise price
- $1.73
- Footnotes
- F1
BBLG
holding
Derivative
Non-Employee Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,721
- Date
- 17 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,721
- Exercise price
- $5.12
- Footnotes
- F2
BBLG
holding
Derivative
Non-Employee Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 154
- Date
- 17 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 154
- Exercise price
- $387.26
- Footnotes
- F2
BBLG
holding
Derivative
Non-Employee Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 37
- Date
- 17 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 37
- Exercise price
- $844.80
- Footnotes
- F2
BBLG
holding
Derivative
Non-Employee Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13
- Date
- 17 Sep 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13
- Exercise price
- $1260.00
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable quarterly through the date of the next annual meeting of stockholders of the Company.
Footnote F2
This option is fully exercisable as of the date of this report.